Ledger.Open graph →
SEC Form D · filed January 11, 2022

Kestrel Therapeutics Inc

Offering
$40.0M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WAYLAND, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Frank G. Haluska · Wayland, MAExec · DirectorDenis G. Patrick · Wayland, MADirectorAndrew G. Phillips · Wayland, MADirectorOmar G. Khalil · Wayland, MADirectorThomas Q. Benedetti · RICHMOND, VAExec · DirectorErin Terjesen · Phoenix, AZExec · DirectorDenis G. Patrick · Wayland, MADirectorAndrew G. Phillips · Wayland, MADirectorOmar G. Khalil · Wayland, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗